Optima Health stock falls after £100 million PAM acquisition deal

Optima Health’s shares fell on the day the company announced a £100 million acquisition of PAM, as investors reacted to concerns over the valuation and integration risks. The announcement, released during the company’s trading session, triggered a sell‑off as market participants questioned whether the price justified the expected synergy benefits. Analysts noted that the deal’s hefty cost could strain Optima Health’s balance sheet and slow its growth trajectory. Despite the deal’s potential to broaden Optima Health’s service portfolio, the immediate market reaction highlights the sensitivity of investors to large‑scale acquisitions and the importance of clear post‑merger integration plans.